References
Akasbi N, Houssaini TS, Rabhi S, Lahlou M, Boukhrissa A, Tahiri L, El Maaroufi C, Berrady R, Harzy T, Bono W (2011) Diffuse uremic tumoral calcinosis in a patient on long-term hemodialysis. J Clin Rheumatol: Pract Rep Rheum Musculoskelet Dis 17(5):272–274
Stevens PE, Levin A (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158(11):825–830
Juppner H (2011) Phosphate and FGF-23. Kidney Int Suppl 121:S24–S27
Eknoyan G, Levin A, Nathan NW (2003) Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(Suppl 3):S1–201
Russo D (2011) Battaglia Y (2011) Clinical significance of FGF-23 in patients with CKD. Int J Nephrol 2011:364890
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Tingting Xie and Yong Zhang contributed equally to this work and are regarded as co-first authors.
Rights and permissions
About this article
Cite this article
Xie, T., Zhang, Y., Tang, X. et al. Amelioration of uremic tumoral calcinosis with high-flux hemodialysis treatment. Int Urol Nephrol 46, 1467–1468 (2014). https://doi.org/10.1007/s11255-014-0654-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-014-0654-9